No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial
2013; Oxford University Press; Volume: 53; Issue: 4 Linguagem: Inglês
10.1093/rheumatology/ket426
ISSN1462-0332
AutoresRené Panduro Poggenborg, Charlotte Wiell, Pernille Bøyesen, Annelies Boonen, Paul Bird, Susanne Juhl Pedersen, IJ Sørensen, Ole Rintek Madsen, Ole Slot, J. Møller, Maria Hasselquist, Olga Kubassova, Mikkel Østergaard,
Tópico(s)Rheumatoid Arthritis Research and Therapies
ResumoObjective. In a comparative conventional MRI, dynamic contrast-enhanced (DCE)-MRI, CT and radiography study, the authors aimed to monitor whether inflammation is reduced or even eliminated and damage halted in PsA patients receiving anti-TNF therapy.
Referência(s)